In support of this concept, ATR/CHK1 pathway inhibition in combination with oncogene expression of H-rasG12V cells elevate H2AX phosphorylation to significantly higher levels than produced in control cells [55], and also ATR/CHK1 inhibitors are highly effective in killing Myc-driven lymphomas [56]. The gene discussed is ATR; the disease is lymphoma.